Alternative lengthening of telomere-based immortalization renders H3G34R-mutant diffuse hemispheric glioma hypersensitive to PARP inhibitor combination regimens.

Anna Laemmerer; Christian Lehmann; Lisa Mayr; Katharina Bruckner; Lisa Gabler; Daniel Senfter; Philipp Meyer; Theresa Balber; Christine Pirker; Carola N Jaunecker

doi:10.1093/neuonc/noae228

Alternative lengthening of telomere-based immortalization renders H3G34R-mutant diffuse hemispheric glioma hypersensitive to PARP inhibitor combination regimens.

Identifier:nobleid.org/w1/20260515/DBC7CAB7

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/DBC7CAB7.svg?ark=w1%2F20260515%2FDBC7CAB7)](https://nobleid.org/work/w1/20260515/DBC7CAB7)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Alternative lengthening of telomere-based immortalization renders H3G34R-mutant diffuse hemispheric glioma hypersensitive to PARP inhibitor combination regimens.

Identifier:nobleid.org/w1/20260515/DBC7CAB7

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/DBC7CAB7.svg?ark=w1%2F20260515%2FDBC7CAB7)](https://nobleid.org/work/w1/20260515/DBC7CAB7)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work